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Abstract
Background: It is widely believed that providing doctors with guidelines will lead to more effective
clinical practice and better patient care. However, different studies have shown contradictory
results in quality improvement as a result of guideline implementation. The aim of this study was
to compare family doctors' knowledge and self-reported care of type 2 diabetes patients with
recommendation standards of the clinical practice guideline.
Methods: In April 2003 a survey was conducted among family doctors in Estonia. The structured
questionnaire focused on the knowledge and self-reported behavior of doctors regarding the
guideline of type 2 diabetes. The demographic and professional data of the respondents was also
provided.
Results: Of the 354 questionnaires distributed, 163 were returned for a response rate of 46%.
Seventy-six percent of the responded doctors stated that they had a copy of the guideline available
while 24% reported that they did not. Eighty-three percent of the doctors considered it applicable
and 79% reported using it in daily practice. The doctors tended to start treatment with medications
and were satisfied with treatment outcomes at higher fasting blood glucose levels than the levels
recommended in the guideline. Doctors' self-reported performance of the tests and examinations
named in the guideline, which should be performed within a certain time limit, varied from overuse
to underuse. Blood pressure, serum creatinine, eye examination and checking patients' ability to
manage their diabetes were the best-followed items while glycosylated hemoglobin and weight
reduction were the most poorly followed. Doctors' behavior was not related to the fact of whether
they had the guideline available, whether they considered it applicable, or whether they actually
used it.
Conclusion:  Doctors' knowledge and self-reported behavior in patient follow-up of type 2
diabetes is very variable and is not related to the reported availability or usage of the guideline.
Practice guidelines may be a useful source of information but they should not be overestimated.
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Background
Clinical practice guidelines (CPG) are systematically
developed statements to assist the decisions of the practi-
tioner and patient about appropriate healthcare for spe-
cific clinical circumstances [1]. It is expected that clinical
practice guidelines improve healthcare quality, reduce
inappropriate variations between providers and predis-
pose dissemination of the evidence-based medicine con-
cept in daily practice. Policymakers and payers see
guidelines as a tool for making healthcare more consistent
and efficient. However, there is no certain evidence that
guidelines may change practice behavior. Different stud-
ies have shown contradictory results in quality improve-
ment as a result of guideline implementation. Some
studies describe improvement in disease management
after guideline dissemination [2-4] but evidence to the
contrary exists that none of the guideline intervention
strategies led to improvements in patient quality of life,
quality of diabetes care or performance activity and adher-
ence to the guideline [5-7]. The potential barriers to phy-
sicians' adherence to guidelines can be divided into three
themes: physician knowledge, attitudes and behavior.
Meanwhile the sequence of the "knowledge-attitude-
behavior" model is important in modifying physicians'
practice patterns [8].
In recent decades care of patients with diabetes type 2
(DM2) has shifted from specialist care to primary care
[9,10]. The same trend has taken place in Estonia where in
the 1990s previous highly specialized primary medical
care was changed into a primary care-oriented and family
doctor-based system [11]. To improve the quality of care,
the Estonian Society of Family Doctors started to develop
national practice guidelines in collaboration with special-
ist societies in 1994. The type 2 diabetes guidelines for
family doctors (FD) are some of the latest, developed in
2000 by a multidisciplinary team, led by FDs and based
on the International Diabetes Federation Europe DM2
guideline [12]. The guidelines was introduced to FDs at an
educational seminar and disseminated by mail for all FD
Society members.
Estonian family doctors' awareness of practice guidelines
has not been assessed before. Hence our aim was to com-
pare FDs' knowledge and self-reported care of type 2 dia-
betes patients with the recommendations of the clinical
practice guideline.
Methods
A questionnaire-based survey was conducted in 2003.
Every second doctor (n = 354) from the list of the Esto-
nian Society of Family Doctors received a questionnaire
by mail. A second mailing with a reminder letter and an
additional questionnaire were sent to those who had not
responded three weeks after the initial mailing. The ques-
tionnaire had been compiled by a research team and had
been piloted before using it in the study.
The questionnaire covered the following items:
Background characteristics
Independent variables included the year of graduation
from medical school, the year of specialization as a family
doctor, practice type and location, practice size and the
number of diabetes patients.
Availability of the guideline
To the questions about the DM2 guideline availability, its
use in daily practice and its estimated applicability, yes/no
responses were required.
Specialist accessibility
The doctors were asked about the possibility to consult an
endocrinologist, the distance to the nearest endocrinolo-
gist and the opportunity to consult an endocrinologist by
telephone.
Following the guideline
The doctors were asked to report the level of blood glu-
cose at which they usually start treatment with medica-
tions if lifestyle changes have been ineffective, and the
level at which they are content with treatment outcome.
In the DM2 guideline, HbAc1 is suggested for assessment
of glucose control and corresponding target levels of cap-
illary plasma glucose levels are provided. In the current
study the doctors were asked to provide the respective fast-
ing capillary plasma glucose levels, as this analysis was
more widely used by the doctors at the time of study per-
formance. The suggested level for starting treatment with
medication is >6.5% for HbAc1 and >6.1 mmol/L (109.8
mg/dl) for capillary plasma glucose.
In the next section the family doctors were asked about
the frequency at which they perform the following tests
and examinations prescribed in the guideline: checking
symptoms/complications, checking the patients' ability to
manage their diabetes, smoking habit, blood pressure,
weight/BMI, foot exam, eye exam, HbAc1, lipids (LDL,
HDL, and TG), urinary protein, urinary albumin, and
serum creatinine. The response options were "once a
month," "at least once every three months," "at least
annually," "rarely," and "I do not consider it necessary."
In the Estonian type 2 diabetes guideline, checking the
patients' ability to manage their diabetes and the blood
pressure measurement is suggested to be performed at
every visit. In case of the latter, the doctors' responses
"every visit" and "at least once every three months"in the
questionnaire were deemed appropriate according to theBMC Family Practice 2006, 7:36 http://www.biomedcentral.com/1471-2296/7/36
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guideline. HbAc1 is recommended to be checked every
three months and other items annually.
Score for adherence to the guideline was calculated for
each physician depending on how many guideline recom-
mendations of 12 test and examinations have been timely
performed according to their self-assessment report. More
frequent performance was assessed as non-adherence as
unneeded use of resources.
Statistical analysis
The obtained responses were entered in a database and
were analysed by SPSS 10.0 (Statistical Package for the
Social Sciences) for Windows. Statistical analysis included
the chi-square test for the categorical variables and analy-
sis of variance for the mean continuous variables. All cal-
culated p-values were two-tailed. The P-values higher than
0.05 were considered insignificant.
Results
Of the 354 doctors who received the questionnaire 46%
(n = 163) responded. There were no significant differences
between respondents in the first and second mailings. The
background characteristics of the respondents in our sam-
ple correspond to that of the members of the Estonian
Family Medicine Society, except for working area. Repre-
sentation of doctors from cities was lower among
respondents (19% vs. 37%) but no difference was found
in any comparison between urban and rural doctors.
Background characteristics and availability of the 
guideline
The mean size of the patient list was 1830 ± 407 and the
average (± SD) working experience 22 ± 7.0 years. Regard-
ing their previous specialty, the majority of the respond-
ents had been district doctors for adults. Fifty-three
percent of the doctors worked in solo practices and the
rest worked in group practices (Table 1).
The median number of diabetes patients in the list was 35.
Seventy-six percent of the respondents stated that the
guideline was available while 24% reported that it was
not. Eighty-three percent of the doctors considered it
applicable and 79% reported using it in daily practice. The
availability and use of the guideline were not related to
working area, practice type and size, previous status before
specialization as an FD, waiting time or distance to an
endocrinologist.
Treatment decision and treatment goals
On average, the doctors tended to start treatment with
medications at higher fasting blood glucose (FBG) levels
than the levels recommended in the guideline (Table 2).
More than half of the doctors made a decision to start
treatment with medications on FBG above 7 mmol/l,
while a few made this decision at FBG values below 6.1
mmol/l (Figure 1). The decision about when to start treat-
ment with medications was not related to whether the
doctors had the guideline available, whether they consid-
ered it applicable, or whether they actually used it. There
were no differences in the treatment behavior depending
on the number of patients with diabetes in the doctors'
list.
Following the guideline
The DM2 guideline includes 12 tests and examinations
which should be performed during the year. According to
the self-reported performance of the tests and examina-
tions, it varied from overuse to underuse (Figures 2, 3).
Blood pressure, serum creatinine, eye examination and
checking patients' ability to manage their diabetes were
the best followed tests and examinations while glyco-
Table 1: Background characteristics of the primary care 
providers according to the previous specialty, type of practice 
and working area
Criterion n %
Status before specialization as a family physician
District doctor for adults 109 67
District pediatrician 36 22
Other specialties 9 6
Family physician through residency 8 5
Type of practice
Solo 85 53
Group 76 47
Working area
Urban 67 42
Rural 63 39
City 30 19
Table 2: Fasting blood glucose values (mmol/l) at which a decision to start treatment with medications was taken and the values at 
which doctors were content with treatment outcome
Mean (SD) Minimum Maximum Standard in DM guideline
Decision to start treatment with medication 7.2 (1.3) 5.5 15.0 6.1
Satisfaction with treatment outcome (glycemic control) 6.8 (1.4) 5.0 14.0 5.5BMC Family Practice 2006, 7:36 http://www.biomedcentral.com/1471-2296/7/36
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sylated hemoglobin and weight reduction were the most
poorly followed. Checking symptoms and complications
as well as checking urinary protein and albumin were per-
formed more often than recommended in the guideline.
According to the score of adherence none of the family
doctors performed all the required tests and examinations
on time (Table 3). At least half of the tests and examina-
tions listed in the guideline were performed on time by
52% of the family doctors. Maximum score 12, was not
reached by any of the doctors. The respondents' behavior
in performing the tests and examinations did not depend
on whether they had the guideline available or whether
they had used it. There also was no difference in the doc-
tors' behavior regarding the reported adherence to the
guideline in terms of background characteristics and spe-
cialist accessibility.
Discussion
The present study assessed whether FDs were aware of and
familiar with the recommendations in the DM2 guideline
and whether this was related to FDs' previous specialty,
background characteristics or specialist accessibility. This
is the first time CPG application has been studied in Esto-
nia.
CPGs have been developed and used in the US for more
than three decades and about 1500 guidelines are availa-
ble for the American Medical Association. This is a large
number of guidelines to expect to be followed. A recent
trend in Estonia is to facilitate the development of differ-
ent guidelines. At present, about 20 guidelines have been
compiled for family doctors. However, as the number of
guidelines is increasing, their usage as well as the actual
awareness of them may decline and expected improve-
ment in the quality of care is questionable.
According to the present study, almost two-thirds of the
family doctors have the DM2 guideline at their disposal,
and the majority of the doctors consider them applicable
and use it in daily practice. This is comparable to the
results of other studies demonstrating a positive attitude
towards CPGs. Eighty-three percent of Israeli family phy-
sicians believed the guideline could be implemented and
75% attained help in the management of patients with
DM [13]. Those findings are significantly different from
several other studies where guidelines are available for
only about one-fourth or less of family physicians, while
even fewer still report using them [14,15]. The reason for
this may be that doctors are sometimes doubtful about
CPGs, and they consider them less useful than other
sources of medical information, as they are developed for
reducing healthcare costs and may not be applicable for
individual patients and for local settings [16,17]. The
usage of the guideline and the knowledge about it may
also depend on how CPGs are distributed and if special
educational activities are undertaken. However, the
results of this study did not reveal any difference in the
provision of diabetes care between the doctors who had
CPGs available and used it in comparison with those who
did not.
Regarding general factors that might influence usage of
CPGs, some studies have shown that younger doctors
considered CPGs more useful than older doctors [18] but
there was no difference in our study.
Decision of treatment
The results of the current study demonstrate that FDs
mostly start treatment at higher FBG levels and the
Table 3: Distribution of the doctors according to the adherence 
to the DM2 guideline (adherence score)
Adherence score Number of doctors Cumulative %
12 0 0
11 0 0
10 1 1
96 5
81 9 2 6
72 7 3 2
63 3 5 2
52 9 7 0
42 6 8 6
31 2 9 3
26 9 7
11 9 8
None 3 100
TOTAL 163 100
Distribution of doctors according to their decision to start  treatment with medications depending on fasting blood glu- cose level Figure 1
Distribution of doctors according to their decision to start 
treatment with medications depending on fasting blood glu-
cose level.
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number of patients whom they considered to be compen-
sated is low. The doctors who had guidelines and used
them reported acting in the same way as those who did
not. This shows that even if FDs had the relevant knowl-
edge, many of them were reluctant to use it. On the other
hand, the knowledge that they use may not have been
derived from CPGs but from other sources.
The overwhelming majority of the FDs in our study
tended to start treatment and were content with treatment
outcome at higher levels of FBG than recommended in
the guideline. It has been similarly reported that Italian
physicians are content with treatment outcome at quite
high FBG levels [19]. Other studies support the idea that
doctors are not fully aware of the recommended criteria of
CPGs for intensive blood glucose treatment [19,20]. Char-
acteristics such as practice location, practice type, list size
and length of experience in our study did not predict the
glycemic control of type 2 diabetic patients, which coin-
cides with the finding of another study [21].
Following the guideline
Despite the fact that the majority of the doctors reported
using the guideline, their knowledge of the tests and
examinations recommended in the guideline were very
variable. Blood pressure measurement was followed best,
which is consistent with the findings from another study
[22]. Of the laboratory tests, the performance of creati-
nine showed the best concordance with the guideline. In
a similar American study, the performance of creatinine,
proteinuria and HbAc1 tests was higher than 90% and
had increased compared with the early nineties [22].
There were significant differences between the perform-
ances of the tests, from underuse to overuse, which might
indicate the preferences of individual doctors. A factor
leading to underuse of laboratory tests might be a lack of
resources, which depends on the healthcare system and
the financial system [11].
Proportions of the doctors and their variation in performing the tests recommended in the guideline Figure 2
Proportions of the doctors and their variation in performing the tests recommended in the guideline. Recom-
mended frequency in the CPG: A – annually, B – every 3 months
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The results of this study showed that regardless of whether
the doctors had the guideline available or not, the process
of diabetes care remained very variable. It can be pre-
sumed that guidelines are not the only source for acquir-
ing knowledge and information.
Following the guideline might be influenced by the guide-
line's dissemination and implementation strategy. It is
evident that a part of Estonian FDs do not have a copy of
the guideline available thus the process of translating dia-
betes guidelines into practice has occurred by diffusion
[23] and partial dissemination [23]. Nevertheless there is
imperfect evidence to support decisions about which
guideline dissemination and implementation strategies
are likely to be efficient under different circumstances
[24].
However, guidelines cannot address all uncertainties in
current clinical practice and should only be seen as one
strategy among others that can help improve the quality
of care that patients receive.
Limitations of the study
Despite the low response rate, the results can still be gen-
eralized as the final structure of the respondents and non-
respondents did not differ from each other. It is quite pos-
sible that self-reported data overestimates the real behav-
ior of the doctors. Hereby according to our data there may
be even more cause for concern for provided care. Even
with these limitations the present study provides valuable
information about the knowledge and behavior of FDs,
who most frequently provide care for DM2 patients in
Estonia.
Conclusion
Guidelines are widely available, and are perceived as a
useful and helpful source by most practitioners. Neverthe-
less, the way FDs take care of patients with diabetes varies
remarkably. Updated and evidence-based guidelines can
be useful as an educational tool but still a knowledge gap
and variable behavior in clinical performance exist.
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Proportions of doctors and their variations in performing the exams recommended in the guideline Figure 3
Proportions of doctors and their variations in performing the exams recommended in the guideline. Recom-
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